OR WAIT null SECS
There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.
The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.
Effective analytics will eliminate failures, deviations, and non-conformances.
November 01, 2008
FDA advocates building quality into a product through PAT.
Efficiency is more than just a buzzword in today's pharmaceutical industry; declining productivity and diminishing returns on investment have made it an over-arching mindset that is critical to corporate survival.
October 30, 2008
Also, Maxygen looks to costs, jobs; Receptor BioLogix appoints Dale R. Pfost CEO; more...
October 23, 2008
Pfizer and UCB formed a technology company named Cyclofluidic with the aim of accelerating the drug-discovery process.
Also, MedImmune opens Cambridge, UK, facility and makes reverse engineering pact with Omninvest; BD Medicine appoints Carol Adiletto VP of clinical and regulatory affairs; more...
October 15, 2008
Also, Millipore opens new membrane-casting manufacturing facility in Ireland; Surface Logix appoints Keith Dionne president, CEO, and a member of the board; more...
October 09, 2008
Also, Merck & Co. discontinues development of its obesity drug taranabant; Synthetech names Frederic Farkas director of manufacturing; more...
October 02, 2008
Advancements add yet another challenge for industry's already overextended regulatory body.
Brief pharmaceutical news items for October 2008.
Can previous trends of Democratic and Republican administrations predict industry's future?